Randomized controlled trial of a remotely-delivered exercise training program in older adults with multiple sclerosis: Secondary effects on cognition, symptoms, and quality of life
Peixuan Zheng , Sydney R. DeJonge , Noah G. DuBose , Ariel Kidwell-Chandler , Trevor B. Martin , Trinh L.T. Huynh , Robert W. Motl
{"title":"Randomized controlled trial of a remotely-delivered exercise training program in older adults with multiple sclerosis: Secondary effects on cognition, symptoms, and quality of life","authors":"Peixuan Zheng , Sydney R. DeJonge , Noah G. DuBose , Ariel Kidwell-Chandler , Trevor B. Martin , Trinh L.T. Huynh , Robert W. Motl","doi":"10.1016/j.msard.2026.107105","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Older adults with multiple sclerosis (MS) experience co-occurring effects of aging and disease progression, resulting in worsening cognition, symptoms, and quality of life (QOL). There is limited research examining approaches for improving those outcomes in older adults with MS.</div></div><div><h3>Objectives</h3><div>We examined the efficacy of a 16-week home-based exercise training program for improving secondary study outcomes of cognition, symptoms, and QOL in older adults with MS.</div></div><div><h3>Methods</h3><div>This phase-Ib, randomized controlled trial (RCT) included 51 participants (60.5±6.6 years, 78% females) who were randomized into exercise training (aerobic and resistance) or active control (stretching) conditions. Participants completed laboratory assessments before and after the 16-week programs. Cognitive function was measured using the NIH Toolbox Cognitive Battery. Symptoms of fatigue, depression, anxiety, and pain were assessed using the Fatigue Severity Scale, Modified Fatigue Impact Scale, Hospital Anxiety and Depression Scale, and Short-form McGill Pain Questionnaire, respectively. QOL was measured by the 29-item Multiple Sclerosis Impact Scale and the 36-Item Short Form Health Survey.</div></div><div><h3>Results</h3><div>Forty-one participants (80.4 %) completed the conditions, with outcome data obtained from 20 exercise and 16 control participants. There were statistically significant improvements in executive function, processing speed, fatigue, and health-related QOL in the exercise group (<em>p</em> < 0.05, <em>d</em> = 0.48–0.66). No significant changes were observed in the control group (<em>p</em>>0.05).</div></div><div><h3>Conclusions</h3><div>We provide preliminary evidence on the benefits of exercise training for improving cognition, reducing fatigue impact, and enhancing QOL in older adults with MS who had moderate disability.</div></div>","PeriodicalId":18958,"journal":{"name":"Multiple sclerosis and related disorders","volume":"109 ","pages":"Article 107105"},"PeriodicalIF":3.0000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple sclerosis and related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211034826001410","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/1 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Older adults with multiple sclerosis (MS) experience co-occurring effects of aging and disease progression, resulting in worsening cognition, symptoms, and quality of life (QOL). There is limited research examining approaches for improving those outcomes in older adults with MS.
Objectives
We examined the efficacy of a 16-week home-based exercise training program for improving secondary study outcomes of cognition, symptoms, and QOL in older adults with MS.
Methods
This phase-Ib, randomized controlled trial (RCT) included 51 participants (60.5±6.6 years, 78% females) who were randomized into exercise training (aerobic and resistance) or active control (stretching) conditions. Participants completed laboratory assessments before and after the 16-week programs. Cognitive function was measured using the NIH Toolbox Cognitive Battery. Symptoms of fatigue, depression, anxiety, and pain were assessed using the Fatigue Severity Scale, Modified Fatigue Impact Scale, Hospital Anxiety and Depression Scale, and Short-form McGill Pain Questionnaire, respectively. QOL was measured by the 29-item Multiple Sclerosis Impact Scale and the 36-Item Short Form Health Survey.
Results
Forty-one participants (80.4 %) completed the conditions, with outcome data obtained from 20 exercise and 16 control participants. There were statistically significant improvements in executive function, processing speed, fatigue, and health-related QOL in the exercise group (p < 0.05, d = 0.48–0.66). No significant changes were observed in the control group (p>0.05).
Conclusions
We provide preliminary evidence on the benefits of exercise training for improving cognition, reducing fatigue impact, and enhancing QOL in older adults with MS who had moderate disability.
期刊介绍:
Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource.
A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.